Treatment of mitochondrial neurogastrointestinal encephalomyopathy with dialysis

Archives of Neurology

Volumn 64, Issue 3, 2007, Pages 435-438

  Yavuz, Halûk ^a   Özel, Ahmet ^a   Christensen, Mette ^b   Christensen, Ernst ^b   Schwartz, Marianne ^b   Elmaci, Mithat ^a   Vissing, John ^b  

^a SELCUK UNIVERSITY   (Turkey)

^b Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYURIDINE; THYMIDINE;

ABDOMINAL PAIN; ADOLESCENT; AMENORRHEA; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DISEASE COURSE; DISEASE DURATION; FEMALE; HUMAN; MENSTRUAL CYCLE; MNGIE SYNDROME; NEUROIMAGING; PRIORITY JOURNAL; RADIODIAGNOSIS; VOMITING; WEIGHT GAIN; WEIGHT REDUCTION;

ADOLESCENT; DEOXYURIDINE; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MITOCHONDRIAL ENCEPHALOMYOPATHIES; PERITONEAL DIALYSIS; THYMIDINE;

EID: 33947197640     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.64.3.435     Document Type: Article

References (13)

1. Nishino I, Spinazzola A, Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science. 1999;283:689-692.
2. Hirano M, Lagier-Tourenne C, Valentino ML, Marti R, Nishigaki Y. Thymidine phosphorylase mutations cause instability of mitochondrial DNA. Gene. 2005;354:152-156.
3. Vissing J, Ravn K, Danielsen ER, et al. Multiple mtDNA deletions with features of MNGIE. Neurology. 2002;59:926-929.
4. Teitelbaum JE, Berde CB, Nurko S, Buonomo C, Perez-Atayde AR, Fox VL. Diagnosis and management of MNGIE syndrome in children: case report and review of the literature. J Pediatr Gastroenterol Nutr. 2002;35:377-383.
5. Spinazzola A, Marti R, Nishino I, et al. Altered thymidine metabolism due to defects of thymidine phosphorylase. J Biol Chem. 2002;277:4128-4133.
6. Giordano C, Sebastiani M, Plazzi G, et al. Mitochondrial neurogastrointestinal encephalomyopathy: evidence of mitochondrial DNA depletion in the small intestine. Gastroenterology. 2006;130:893-901.
7. Hirano M, Nishigaki Y, Marti R. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a disease of two genomes. Neurologist. 2004;10:8-17.
8. Bedlack RS, Vu T, Hammans S, et al. MNGIE neuropathy: five cases mimicking chronic inflammatory demyelinating polyneuropathy. Muscle Nerve. 2004;29:364-368.
9. Song S, Wheeler LJ, Mathews CK. Deoxyribonucleotide pool imbalance stimulates deletions in HeLa Cell mitochondrial DNA. J Biol Chem. 2003;278:43893-43896.
10. la Marca G, Malvagia S, Casetta B, et al. Pre- and post-dialysis quantitative dosage of thymidine in urine and plasma of a MNGIE patient by using HPLC-ESI-MS/MS. J Mass Spectrom. 2006;41:586-592.
11. Lara MC, Vais B, Illa I, et al. Infusion of platelets transiently reduces nucleoside overload in MNGIE. Neurology. 2006;67:1461-1463.
12. Hirano M, Marti R, Casali C, et al. Allogenic stem cell transplantation corrects biochemical derangements in MNGIE. Neurology. 2006;67:1458-1460.
13. Kocaefe YC, Erdem-Özdamar S, Sivri HS, Coskun T, Tan E, Özgüc M. Comprehensive analysis reveals distinct mtDNA features in Mitochondrial Neurogastrointestinal Encephalomyopathy Syndrome (MNGIE) [abstract]. Neuromuscul Disord. 2006;16(suppl 1):S57-S58.